These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 24304573)
21. Antioxidative and immunomodulatory effects of tributyrin supplementation on experimental colitis. Leonel AJ; Teixeira LG; Oliveira RP; Santiago AF; Batista NV; Ferreira TR; Santos RC; Cardoso VN; Cara DC; Faria AM; Alvarez-Leite J Br J Nutr; 2013 Apr; 109(8):1396-407. PubMed ID: 22906779 [TBL] [Abstract][Full Text] [Related]
22. Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice. Mishra SK; Kang JH; Kim DK; Oh SH; Kim MK J Ethnopharmacol; 2012 Sep; 143(2):524-32. PubMed ID: 22819687 [TBL] [Abstract][Full Text] [Related]
23. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair. Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600 [TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor gamma in the colon: inflammation and innate antimicrobial immunity. Speca S; Dubuquoy L; Desreumaux P J Clin Gastroenterol; 2014; 48 Suppl 1():S23-7. PubMed ID: 25291120 [TBL] [Abstract][Full Text] [Related]
25. Establishment and validation of a new semi-chronic dextran sulfate sodium-induced model of colitis in mice. Sha T; Igaki K; Yamasaki M; Watanabe T; Tsuchimori N Int Immunopharmacol; 2013 Jan; 15(1):23-9. PubMed ID: 23142502 [TBL] [Abstract][Full Text] [Related]
26. Prophylactic effects of Lonicera japonica extract on dextran sulphate sodium-induced colitis in a mouse model by the inhibition of the Th1/Th17 response. Park JW; Bae H; Lee G; Hong BG; Yoo HH; Lim SJ; Lee K; Kim J; Ryu B; Lee BJ; Bae J; Lee H; Bu Y Br J Nutr; 2013 Jan; 109(2):283-92. PubMed ID: 22569277 [TBL] [Abstract][Full Text] [Related]
27. Troglitazone, a ligand for peroxisome proliferator-activated receptor gamma, inhibits chemically-induced aberrant crypt foci in rats. Kohno H; Yoshitani S; Takashima S; Okumura A; Hosokawa M; Yamaguchi N; Tanaka T Jpn J Cancer Res; 2001 Apr; 92(4):396-403. PubMed ID: 11346461 [TBL] [Abstract][Full Text] [Related]
28. In-vivo antioxidant and anti-inflammatory activity of rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonists in animal model of bronchial asthma. El-Naa MM; El-Refaei MF; Nasif WA; Abduljawad SH; El-Brairy AI; El-Readi MZ J Pharm Pharmacol; 2015 Oct; 67(10):1421-30. PubMed ID: 26099551 [TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331 [TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor gamma activation promotes intestinal barrier function by improving mucus and tight junctions in a mouse colitis model. Zhao J; Zhao R; Cheng L; Yang J; Zhu L Dig Liver Dis; 2018 Nov; 50(11):1195-1204. PubMed ID: 29891333 [TBL] [Abstract][Full Text] [Related]
31. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats. Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576 [TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptor gamma ligand prevents the development of chronic pancreatitis through modulating NF-kappaB-dependent proinflammatory cytokine production and pancreatic stellate cell activation. Hisada S; Shimizu K; Shiratori K; Kobayashi M Rocz Akad Med Bialymst; 2005; 50():142-7. PubMed ID: 16358954 [TBL] [Abstract][Full Text] [Related]
33. Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis. Camuesco D; Comalada M; Concha A; Nieto A; Sierra S; Xaus J; Zarzuelo A; Gálvez J Clin Nutr; 2006 Jun; 25(3):466-76. PubMed ID: 16698151 [TBL] [Abstract][Full Text] [Related]
34. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice. Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649 [TBL] [Abstract][Full Text] [Related]
37. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism. Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073 [TBL] [Abstract][Full Text] [Related]
38. Beneficial effect of glatiramer acetate treatment on syndecan-1 expression in dextran sodium sulfate colitis. Yablecovitch D; Shabat-Simon M; Aharoni R; Eilam R; Brenner O; Arnon R J Pharmacol Exp Ther; 2011 May; 337(2):391-9. PubMed ID: 21310817 [TBL] [Abstract][Full Text] [Related]
39. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines. Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697 [TBL] [Abstract][Full Text] [Related]
40. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia. Liu D; Zeng BX; Zhang SH; Yao SL Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]